Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,650,964 papers from all fields of science
Search
Sign In
Create Free Account
TB 402
Known as:
TB-402
, TB402 monoclonal antibody
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
P. Verhamme
,
S. Gunn
,
+8 authors
M. Tangelder
Thrombosis and haemostasis
2013
Corpus ID: 26641558
TB-402 is a long-acting monoclonal antibody that partially inhibits factor VIII. A single administration of TB-402 was effective…
Expand
2012
2012
Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis.
J. Emmerechts
,
T. Vanassche
,
+7 authors
P. Verhamme
Thrombosis research
2012
Corpus ID: 2247626
2012
2012
Antidote strategies to reverse anticoagulation with TB‐402, a long‐acting partial inhibitor of factor VIII
M. Tangelder
,
C. Long
,
+7 authors
P. Verhamme
Journal of thrombosis and haemostasis : JTH
2012
Corpus ID: 23736697
Summary. Background: TB‐402 is a partially inhibiting antibody of factor VIII that is under development as a long‐acting…
Expand
2011
2011
Single intravenous administration of TB‐402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose‐escalating, randomized, controlled trial
P. Verhamme
,
M. Tangelder
,
+5 authors
H. Büller
Journal of thrombosis and haemostasis : JTH
2011
Corpus ID: 32634012
Summary. Background: TB‐402 is a novel anticoagulant monoclonal antibody with a prolonged antithrombotic effect resulting from…
Expand
Review
2011
Review
2011
New parenteral anticoagulants in development
A. Gómez-Outes
,
M. Suárez-Gea
,
R. Lecumberri
,
E. Rocha
,
C. Pozo-Hernández
,
E. Vargas‐Castrillón
Therapeutic advances in cardiovascular disease
2011
Corpus ID: 36442831
The therapeutic armamentarium of parenteral anticoagulants available to clinicians is mainly composed by unfractionated heparin…
Expand
2011
2011
Effects of a FVIII inhibitor TB-402 on coagulation: reversibility with pro-coagulants
C. Long
,
P. Verhamme
,
J. Emmerechts
,
M. Hoylaerts
,
M. Jacquemin
,
P. Giesen
2011
Corpus ID: 78513901
2010
2010
Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
P. Verhamme
,
S. Pakola
,
+10 authors
M. Jacquemin
Clinical therapeutics
2010
Corpus ID: 39241623
2010
2010
Single intravenous administration of TB-402 for the prophylaxis of VTE after total knee replacement surgery
P. Verhamme
,
R. Verhaeghe
,
+5 authors
M. Jacquemin
2010
Corpus ID: 74731338
Total VTE was lower in each of the TB-402 groups compared to the enoxaparin group: 16.7% (9.8-26.9), 23.9% (15.3-35.3), 24.1%(16…
Expand
2009
2009
Thrombogram analysis of the long-acting anticoagulant effect of TB-402, a human anti-FVIII antibody, and of its interactions with rHVFIII, LMWH and Warfarin in healthy volunteers
P. Verhamme
,
S. Pakola
,
+8 authors
M. Jacquemin
2009
Corpus ID: 79094417
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE